|
Volumn 80, Issue 3, 1998, Pages 367-368
|
Use of angiotensin-converting enzyme inhibitors in patients with diabetic and nondiabetic chronic renal diseases: A need for reassessment [10]
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BENAZEPRIL;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CAPTOPRIL;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ENALAPRIL;
FUROSEMIDE;
NIFEDIPINE;
PRAZOSIN;
THIAZIDE DIURETIC AGENT;
ADULT;
AGED;
CHRONIC KIDNEY DISEASE;
CLINICAL ARTICLE;
CONGESTIVE HEART FAILURE;
CREATININE BLOOD LEVEL;
DIABETES MELLITUS;
FEMALE;
HUMAN;
HYPERTENSION;
LETTER;
MALE;
NEPHROTOXICITY;
POTASSIUM BLOOD LEVEL;
PRIORITY JOURNAL;
ADULT;
AGED;
AGED, 80 AND OVER;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
CHRONIC DISEASE;
DIABETIC NEPHROPATHIES;
FEMALE;
HUMANS;
KIDNEY DISEASES;
MALE;
MIDDLE AGED;
|
EID: 0031755483
PISSN: 00282766
EISSN: None
Source Type: Journal
DOI: 10.1159/000045206 Document Type: Letter |
Times cited : (2)
|
References (5)
|